Black Diamond Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Black Diamond Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q3 2024.
  • Black Diamond Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 654 %, a 21.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 654 -180 -21.6% Sep 30, 2024
Q2 2024 752 -7.26 -0.96% Jun 30, 2024
Q1 2024 753 -52.3 -6.49% Mar 31, 2024
Q4 2023 784 -56.5 -6.72% Dec 31, 2023
Q3 2023 834 -28.2 -3.28% Sep 30, 2023
Q2 2023 760 -153 -16.8% Jun 30, 2023
Q1 2023 805 -181 -18.3% Mar 31, 2023
Q4 2022 841 -271 -24.4% Dec 31, 2022
Q3 2022 862 -503 -36.8% Sep 30, 2022
Q2 2022 913 -894 -49.5% Jun 30, 2022
Q1 2022 986 -1.32K -57.2% Mar 31, 2022
Q4 2021 1.11K -2.03K -64.6% Dec 31, 2021
Q3 2021 1.36K -2.22K -61.9% Sep 30, 2021
Q2 2021 1.81K Jun 30, 2021
Q1 2021 2.3K Mar 31, 2021
Q4 2020 3.14K Dec 31, 2020
Q3 2020 3.58K Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.